Mineralys Therapeutics

(NASDAQ) MLYS

Current Price$25.88

Market Cap$2.27B

Since IPO (2023)+39%

5 YearN/A

1 Year+82%

1 Month-14%

Mineralys Therapeutics Financials at a Glance

Market Cap

$2.27B

Revenue (TTM)

$0.00

Net Income (TTM)

-$151.78M

EPS (TTM)

-$2.06

P/E Ratio

-12.52

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$25.88

Volume

1,453,010

Open

$25.61

Price

$25.88

Volume

1,453,010

Open

$25.61

Previous Close

$25.78

Daily Range

$25.50 - $26.35

52-Week Range

$12.59 - $47.65

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$25.88

Volume

1,453,010

Open

$25.61

Previous Close

$25.78

Daily Range

$25.50 - $26.35

52-Week Range

$12.59 - $47.65

Estimated Earnings Date

Aug 11, 2026

MLYS News

What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision

Jonathan PoncianoJun 23, 2026

Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million

Cory RenauerMay 31, 2026

Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?

Robert IzquierdoApr 7, 2026

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears

Jonathan PoncianoDec 23, 2025

This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys

Jonathan PoncianoNov 27, 2025

MLYS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mineralys Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jon Congleton

Website

www.mineralystx.com

Headquarters

Radnor, PA 19087, US

MLYS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-27.92%

Return on Capital

-26.38%

Return on Assets

-23.25%

Earnings Yield

-7.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.27B

Shares Outstanding

88.16M

Volume

1.45M

Avg. Volume

1.50M

Financials (TTM)

Gross Profit

-$21.00K

Operating Income

-$171.50M

EBITDA

-$151.73M

Operating Cash Flow

-$136.40M

Capital Expenditure

-$15.00K

Free Cash Flow

-$136.42M

Cash & ST Invst.

$646.06M

Total Debt

$0.00

Mineralys Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$6.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.27B

N/A

Market Cap/Employee

$44.55M

N/A

Employees

N/A

Net Income

-$39.34M

+6.8%

EBITDA

-$39.33M

+6.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$646.06M

+88.3%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-23.25%

N/A

Return on Invested Capital

-26.87%

N/A

Free Cash Flow

-$39.47M

+13.2%

Operating Cash Flow

-$39.47M

+13.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AGIOAgios Pharmaceuticals, Inc.

AGIOAgios Pharmaceuticals, Inc.$36.28+1.94%

ZLABZai Lab Limited

ZLABZai Lab Limited$18.37-0.65%

ADPTAdaptive Biotechnologies Corporation

ADPTAdaptive Biotechnologies Corporation$19.34+12.25%

RXRXRecursion Pharmaceuticals, Inc.

RXRXRecursion Pharmaceuticals, Inc.$3.23+2.22%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$36.28+3.92%

BEAMBeam Therapeutics Inc.

BEAMBeam Therapeutics Inc.$33.90+2.11%

CPRXCatalyst Pharmaceuticals, Inc.

CPRXCatalyst Pharmaceuticals, Inc.$31.42+0.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.86+0.26%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.44+0.08%

SOFISoFi Technologies

SOFISoFi Technologies$17.31+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

PATHUiPath

PATHUiPath$10.31+0.01%

PFEPfizer

PFEPfizer$24.04-0.03%

Questions About MLYS

What is the current price of Mineralys Therapeutics?

Mineralys Therapeutics is trading at $25.78 per share.

What is the 52-week range for Mineralys Therapeutics?

Over the past 52 weeks, Mineralys Therapeutics has traded between $12.59 and $47.65.

How much debt does Mineralys Therapeutics have?

As of the most recent reporting period, Mineralys Therapeutics reported total debt of $0.00.

How much cash does Mineralys Therapeutics have on hand?

Mineralys Therapeutics reported $112.78M in cash and cash equivalents in its most recent financial results.

What is Mineralys Therapeutics’s dividend yield?

Mineralys Therapeutics does not currently have a dividend yield.

Mineralys Therapeutics

Mineralys Therapeutics Financials at a Glance

MLYS News

What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision

Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million

Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears

This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys

MLYS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mineralys Therapeutics

MLYS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mineralys Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MLYS

What is the current price of Mineralys Therapeutics?

What is the 52-week range for Mineralys Therapeutics?

How much debt does Mineralys Therapeutics have?

How much cash does Mineralys Therapeutics have on hand?

What is Mineralys Therapeutics’s dividend yield?

Premium Investing Services